Friday, 20 Oct 2017

You are here

CDC Shows a 40% Lifetime Risk of Symptomatic Hand Osteoarthritis

Qin and colleagues have published in Arthritis & Rheumatology that 40% of people will be affected by symptomatic osteoarthritis in at least one hand.  (Citation source: http://buff.ly/2qTUscZ)  

They analyzed 2,218 adults ≥ 45 years from the Johnston County (NC) Osteoarthritis Project, specifically collecting looking for symptomatic hand OA (SHOA) over two time frames (1999-2004 and 2005-2010). SHOA was defined as having both self-reported symptoms and radiographic OA in the same hand.

The found the lifetime risk of SHOA is 39.8% with greater frequency in women as they age.  Women by age 85 yrs had a 47.2% frequency of SHOA compared to only 24.6% in men.

Hand OA was more common in whites moreso than blacks (41.4% vs 29.2%, respectively). The lifetime risk in the obese was 47.1 percent, compared to 36.1 percent for non-obese people.

Hand OA represents a significant publich health problem for which there are few, if any, credible treatment options.  Dr. Marc Hochberg and coworkers at OARSI have submitted a 103 page "white paper" to  FDA to designate OA as a "Serious Disease", staging that OA is a "serious disease for which there are no current satisfactory treatments". (Citation source: http://buff.ly/2pTuVm1)

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Zilretta - a New Drug FDA Approved for Osteoarthritis of the Knee

Flexion Therapeutics announced friday that the U.S. Food and Drug Administration (FDA) has approved its osteoarthritis (OA) of the knee injectable steroid drug Zilretta with the indication of moderate-to-severe knee pain.

Zilretta is the commonly used triamcinolon acetonide combined with a drug delivery system designed to provide extended pain relief over three months.

UAB Researchers Shed Light on Age-Related Osteoporosis

Researchers from the University of Alabama at Birmingham (UAB) have detailed mechanisms leading to age-related bone loss and osteoporosis.

Osteoporotic Fractures as Back Pain in Older Men

The Journal of Bone and Mineral Research reports that older men with undiagnosed vertebral fractures are likely to report new or worsening back pain. (Citation source bit.ly/2y9rMiZ)

Romosuzumab Followed by Alendronate is Best in Fracture Prevention

The NEJM reports that in high risk post-menopausal women, romosozumab for 12 months followed by alendronate resulted in a significantly lower fracture than alendronate alone. 

Bad Knees Through the Ages

The average American today is twice as likely to be diagnosed with knee osteoarthritis as in the years before World War II, Harvard scientists say. And the reasons are less clear than you might think.

Based on a study of more than 2,000 skeletons from cadaveric and archaeological collections across the United States, a Harvard report is the first to definitively show that knee osteoarthritis prevalence has dramatically increased in recent decades.